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Abstract
Background: Anaemia is a common manifestation of paediatric HIV infection. Although there are
many causes, anaemia of chronic diseases is the most frequent type. In poor countries iron
deficiency is widespread. It is probable that many HIV-infected children in these countries are also
iron deficient. This study describes the relationship between paediatric HIV infection and anaemia,
and documents the peripheral iron status of antiretroviral naive, HIV-infected children.
Methods: Sixty children were evaluated prospectively. Investigations included CD4+ count,
haemoglobin concentration (Hb), red blood cell (RBC) morphology, and iron studies.
Results: Anaemia was present in 73% of children. Compared to mild HIV infection, median Hb was
lower in children with moderate clinical infection (104 g/L v 112 g/L, p = 0.04) and severe clinical
infection (96 g/L v 112 g/L, p = 0.006), and more children with severe infection were anaemic (92%
v 58%, 0.04). There was a significant relationship between immunological status and Hb. 68% had
abnormal RBC morphology. Significantly more children with moderate and severe disease, and
severe immunosuppression had abnormal RBC morphology. 52% were iron-depleted, 20% had
iron-deficient erythropoiesis and 18% iron deficiency anaemia (IDA). 16% (7/44) of anaemic
children had microcytosis and hypochromia. Median soluble transferrin receptor concentration
was significantly higher in those with microcytic hypochromic anaemia (42.0 nmol/L v 30.0 nmol/L,
p = 0.008).
Conclusions: Both the proportion of anaemic children and the median Hb were associated with
disease status. Iron depletion and IDA are major problems in HIV-infected children in South Africa.
Background
Anaemia is a common manifestation of paediatric HIV in-
fection and is a significant negative predictor of survival
[1,2]. Although there are many causes of HIV-associated
anaemia, anaemia of chronic diseases (ACD) is the most
frequent type [3], inflammatory cytokines released during
chronic diseases inhibit erythropoiesis, blunt the erythro-
poietin response, reduce red blood cell survival and pre-
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system, leading to the development of ACD [3,4].
Iron deficiency is widespread in children in developing
countries. A recent nutritional survey showed that approx-
imately 20% of South African children were anaemic and
10% iron deficient. In this survey HIV status was not re-
corded [5]. Another study conducted on Italian children
documented iron deficiency, caused by intestinal malab-
sorption, in a large proportion of HIV-infected children
[6]. Because of the high prevalence of iron deficiency
among South African children, it is probable that many
HIV-infected children are also iron deficient. This report
documents the relationship between paediatric HIV infec-
tion and anaemia and describes the peripheral iron status
of HIV-infected children in an economically deprived set-
ting.
Methods
A prospective, cross-sectional study was performed on 60
clinically stable, antiretroviral naïve, HIV-infected chil-
dren attending the HIV clinic at Red Cross War Memorial
Children's Hospital in Cape Town. The ambulatory man-
agement of children who attend the clinic includes cotri-
moxazole prophylaxis, treatment of minor infections and
nutritional and micronutrient supplementation. Antiret-
roviral therapy is not routinely administered to HIV-in-
fected children in South Africa. Children were considered
eligible for inclusion if they were relatively well i.e. they
had had no acute illness or febrile episode in the preced-
ing 7 days, nor hospitalised in the preceding 14 days.
Children were excluded if they were acutely ill. The first 2
or 3 children seen at each weekly clinic over an 8 month
period were enrolled, after their parents were counselled
and written consent obtained. The Research Ethics Com-
mittee of the University of Cape Town approved the study.
Children were diagnosed and classified into clinical and
immunological categories according to CDC criteria [7].
CD4+ lymphocyte counts were measured on EDTA-anti-
coagulated whole blood samples using an EPICS Profile II
flow cytometer (Coulter Corporation, Hialeah, Florida)
[8]. Haemaglobin concentration (Hb), red blood cell
(RBC) indices [mean corpuscular volume (MCV), mean
corpuscular haemaglobin (MCH), mean corpuscular hae-
maglobin concentration (MCHC) and red blood cell dis-
tribution width (RDW)] and RBC morphology were
determined on EDTA-anti-coagulated blood samples us-
ing a Coulter MAXM (Coulter Corporation), according to
the manufacturer's instructions. Red blood cell morphol-
ogy was validated by light microscopy, on May Grune-
wald Giemsa stained samples [9].
Evaluation of iron status was performed on heparinised
plasma. Ferritin concentration was measured by commer-
cial immunoassay (Spectro Ferritin®, Ramco laboratories,
Houston, Texas), iron concentration (Fe) by direct spec-
trophotometry on a RA 1000 analyser, model TM34-
E1120/115CV (Bayer – Technicon Instruments Corpora-
tion, New York) using a commercial kit (MPR Iron with-
out deproteinisation, Roche Diagnostics Corp.,
Indianapolis), and transferrin concentration by
nepholometry on a Behring nepholometer, model BN
100 with commercial antisera (Behringwerke AG, Mar-
burg, Germany). Total iron binding capacity (TIBC) was
calculated using the formula: TIBC (µg/dl) = (Transferrin
× 200) ÷ 8 [10]. Transferrin saturation (TS) was deter-
mined as follows: TS = (Plasma iron concentration ÷ TI-
BC) × 100 [11]. Results were compared to locally derived
normal age-related values. The following definitions were
used in the analysis (i) iron depletion: ferritin < 10 µg/L,
(ii) iron-deficient erythropoiesis: ferritin < 10 µg/L and at
least 3 of the following criteria: Fe < 8.8 µmol/L, TIBC >
71.6 µmol/L, TS < 10%, MCV less than normal age-related
values and MCH less than normal age-related values, and
(iii) iron deficiency anaemia (IDA): criteria for iron-defi-
cient erythropoiesis plus Hb less than the normal age-re-
lated range [12,13]. Soluble transferrin receptor
concentration (sTfR.) was measured on serum samples us-
ing a commercial immunoassay (Quantikine™ IVD™ sTfR.
assay, R&D Systems, Minneapolis, Minnesota). Soluble
transferrin receptor concentration results were used in the
comparative analyses.
Data was collated and analysed using Epi Info version
6.04, Division of Surveillance and Epidemiology, CDC,
Atlanta, Georgia. Categorical and continuous data were
compared using the Chi-squared and Kruskal Wallis tests
respectively. The Spearman rank correlation test was used
to determine the relationship between different continu-
ous variables. A p value < 0.05 was considered significant.
Results
The median age (quartiles) was 25.0 months (13.0, 37.8).
The male to female ratio was 1.0:0.9. The diagnosis of HIV
infection was established by polymerase chain reaction in
73% (44/60) i.e. children less than 18 months of age and
by ELISA in 27% (16/60) i.e. children more than 18
months of age. Mild clinical features of HIV infection
(Category A) were present in 32% (19/60), moderate fea-
tures (Category B) in 48% (29/60) and severe features
(Category C) in 20% (12/60). Twenty per cent (12/60)
had no evidence of immunosuppression (Category I),
35% (21/60) were moderately immunosuppressed (Cate-
gory II) and 45% (27/60) were severely immunosup-
pressed (Category III). The median age was significantly
lower in category C when compared to category A (13.5
months v 28.0 months, p = 0.03) and category B (13.5
months v 30 months, p = 0.02). There was no significant
age differences between the immunological categories.Page 2 of 6
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ed reference values. The median Hb was 104 g/L (96,
110). Seventy two per cent had a Hb less than 110 g/L.
Two children had a Hb less than 80 g/L. Compared to Cat-
egory A, the median Hb was significantly lower in Catego-
ry B (104 g/L v 112 g/L, p = 0.04) and Category C (96 g/L
v 112 g/L, p = 0.006). Compared to Category A, more chil-
dren in Category C were anaemic (92% v 58%, p = 0.04).
The proportion of children with anaemia in Category B
was greater than Category A (76% v 58%, p = 0.2), but this
was not significant. Median Hb was significantly lower in
Category III compared to Category I (99 g/L v 110 g/L, p =
0.003). The median Hb was lower in Category II than in
Category I (104 g/L v 110 g/L, p = 0.07), but this was not
significant. Compared to Category I, more children in
Category II (76% v 42%, p = 0.04) and Category III (85%
v 42%, p = 0.005) were anaemic. Median Hb did not cor-
relate with age (r = 0.35, 95% confidence interval-0.14,
0.36).
Many children had abnormal RBC indices and altered pe-
ripheral iron results (Table 1I). Red blood cell morpholo-
gy showed anisocytosis in 68% (41/60), polychromasia in
17% (10/60), target cells in 15% (9/60) and microcytosis
plus hypochromia in 12% (7/60). Thirty two per cent (19/
60) had normal RBC morphology. In comparison to Cat-
egory A more children in Category B (76% v 42%, p =
0.006) and Category C disease (92% v 42%, p = 0.02) had
abnormal RBC morphology. Significantly more children
in Category III than Category I had abnormal morphology
(89% v 42%, p = 0.002). A larger proportion in Category
II had abnormal morphology relative to Category I (67%
v 42%, p = 0.4); this difference was not statistically signif-
icant.
Fifty two per cent (31/60) of the children were iron-de-
pleted, 18% (11/60) had iron-deficient erythropoiesis
and 17% (10/60) IDA. Of the 11 patients with iron-defi-
cient erythropoiesis 2 fulfilled all diagnostic criteria, 3 ful-
filled 4 criteria and 6 fulfilled 3 criteria. Forty five per cent
(20/44) of all anaemic children were iron-depleted. Table
2II compares anaemic children with low plasma ferritin
concentrations and those with ferritin concentrations > 10
µg/L. With exception of transferrin and TIBC, measures of
iron status are not significantly different between the two
groups. Thirteen per cent (8/60) of the anaemic children
had a ferritin concentration greater than 100 µg/L. Chil-
dren with microcytic, hypochromic anaemia had signifi-
cantly higher sTfR. The ferritin concentration of these
children ranged from 4.9 µg/L to 49 µg/L. Four of these
seven children had a ferritin concentration < 10 µg/L.
Other measures of iron status were not significantly differ-
ent between the groups of children with or without micro-
cytic, hypochromic anaemia (Table 3III). Median sTfR
was significantly higher in category C compared to catego-
ry A (35.5 nmol/L v 26.0 nmol/L, p = 0.01). There was no
association between sTfR and immunological category.
Discussion
A large number of stable, HIV-infected children were
anaemic. Few had severe anaemia. Furthermore, both the
proportion of children with anaemia and median haema-
globin concentration were associated with clinical and
immunological status. There was no association between
Hb and chronological age. Studies of infected children
and adults indicate that anaemia independently predicts
poor outcome [2,14,15]. The results of the present study
are in agreement with these observations, as significantly
more children with severe clinical features and severe im-
munosuppression were anaemic.
Many children had abnormal red blood cell morphology.
Anisocytosis was the most frequent observation. It usually
correlates with an increased red blood cell distribution
Table I: Laboratory measurements of iron status (n = 60)
Variable Median concentration (quartiles) Percentage below normal age-range Percentage above normal age-range
Hb (g/L) 104 (96, 111) 73 2
MCV (fL) 76.4 (74.1,80.5) 20 0
MCH (pg) 26.3 (24.6, 27.7) 20 2
MCHC (g/dL) 34.3 (33.4, 35.0) 0 0
RDW (%) 16.2(14.9, 17.6) 0 62
Ferritin (µg/L) 9.0 (4.9, 36.5) 52* 2
Iron (µmol/L) 4.0(2.1,7.7) 75 2
Transferrm (g/L) 2.6 (2.2, 2.9) 32 0
TIBC (µmol/L) 65.4 (55.4, 74.7) 0 33
TS (%) 6.0(4.1, 10.7) 70+ 0
* Per cent < 10 µg/L, Per cent < 10%Page 3 of 6
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non-specific feature that may be present in any red blood
cell disorder, including IDA and ACD [17]. Interestingly,
there was a statistically significant relationship between
disease status and red blood cell morphology. More chil-
dren with severe clinical disease and severe immunosup-
pression had abnormal morphology. These findings were
similar to the relationship between disease status and
anaemia, and reflect the connection between abnormal
morphology and anaemia.
Distinguishing IDA from ACD in chronic inflammatory
diseases may be a problem, as many of the laboratory
measurements used to evaluate iron status are affected in
a similar manner [18]. Ferritin concentration remains the
most practical measurement for evaluating iron stores. A
low concentration (< 10 µg/L) unequivocally identifies
iron-depleted stores. Ferritin is an acute phase reactant.
Therefore, levels may be falsely normal in chronic inflam-
matory diseases such as HIV infection, despite the pres-
ence of iron depletion [12,13]. Elevated ferritin levels,
often exceeding 1000 µg/L have been recorded in adults
with acquired immunodeficiency syndrome [3]. In the
present study, 45% (20/44) of all anaemic children were
iron-depleted. A comparison of the laboratory results of
anaemic children with or without hypoferritinaemia (Ta-
ble 2II) showed few statistically significant differences be-
tween the two groups. In particular, sTfR was not
significantly different between the two groups. Failure to
show a clear distinction between these groups confirms
the complex relationship between iron depletion, iron de-
ficiency anaemia and anaemia of chronic disorders in HIV
infection.
The present study employed strict criteria to identify chil-
dren with IDA. These criteria were adapted from previous-
Table II: Comparison of anaemic children with plasma ferritin concentration < 10 µg/L (Group A) or ≥ 10 µg/L (Group B)
Variable Group A (n = 20) Median (quartiles) Group B (n = 24) Median (quartiles) P value
Hb (g/L) 103 (97,108) 95 (87,104) 0.04
MCV (fL) 75.2(71.4,78.6) 76.3(71.9,81.6) 0.3
MCH (pg) 25.6(23.5,26.4) 26.3 (24.2, 28.3) 0.2
MCHC (g/dL) 33.6(32.9,34.3) 34.2 (33.2, 34.3) 0.2
RDW (%) 17.0(16.1,18.1) 16.6(15.4, 17.8) 0.7
Ferritin (µg/L) 4.9 (4.9, 7.0) 46.5(23.5, 117) < 0.001
Iron (µmol/L) 3.7 (2.0, 5.7) 3.2 (2.0, 6.9) 0.8
Transferrm (g/L) 2.9(2.5,3.1) 2.2(1.9,2.6) < 0.001
TIBC (µmol/L) 71.5(63.4,78.2) 54.9 (46.5, 65.9) < 0.001
TS (%) 4.9 (3.5, 7.3) 5.1(4.1, 10.1) 0.5
sTfR (nmol/L) 32.0(29.3,38.5) 30.0 (22.8, 39.0) 0.3
Table III: Comparison of anaemic children with (Group I) or without (Group II) microcytosis plus hypochromia
Variable Group I (n = 7) Median (quartiles) Group II (n = 37) Median (quartiles) P value
Hb (g/L) 96 (87, 99) 101(94,105) 0.2
MCV (fL) 67.2 (65.2, 68.2) 76.4(74.6,81.0) < 0.001
MCH (pg) 22.0(21.1,23.2) 26.2 (25.0, 27.8) < 0.001
MCHC (g/dL) 33.1 (32.6,34.1) 34.2 (33.4, 34.6) 0.08
RDW (%) 16.8(16.2, 18.0) 16.6(15.2,18.0) 0.4
Ferritin (µg/L) 8.0 (4.9, 38.0) 15.0(5.0,87) 0.3
Iron (µmol/L) 2.7 (2.0, 6.5) 3.5 (2.0, 5.7) 0.8
Transferrm (g/L) 2.8(2.6,3.1) 2.6 (2.0, 2.9) 0.1
TIBC (µmol/L) 69.3 (64.5, 77.5) 63.8(50.5,73.0) 0.1
TS (%) 3.7 (2.9, 9.0) 5.2(4.1,9.0) 0.1
sTfR (nmol/L) 42.0(35.0,45.0) 30.0 (25.0, 36.0) 0.008Page 4 of 6
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age-related values were taken into consideration the crite-
ria were similar to those used internationally [12,13]. The
results probably under-represent the true extent of IDA.
For example, only four children with microcytic, hy-
pochromic anaemia had low ferritin concentrations. They
were included in the IDA group. The other three with mi-
crocytic, hypochromic anaemia were excluded, although
they had significantly elevated soluble transferrin receptor
concentrations, in keeping with IDA (Table 3III). Despite
these omissions, the results suggest that IDA is more prev-
alent in HIV-infected children than in the general paediat-
ric population in South Africa [5].
Soluble tranferrin receptor is not an acute phase reactant.
It is considered more reliable than ferritin to distinguish
IDA from ACD in acute and chronic inflammatory diseas-
es. In IDA sTfR is elevated and in ACD sTfR remains nor-
mal [13,18]. In the present study, sTfR of anaemic
children with or without hypoferrritinaemia were not sig-
nificantly different. However, those with microcytic, hy-
pochromic anaemia had significantly elevated sTfR. The
results suggest that many HIV-infected children with anae-
mia probably have a combination of ACD and iron deple-
tion, a smaller proportion have IDA and some children
with normal ferrritin concentrations have IDA. Only
those with classic findings of IDA had predictably high
soluble transferrin receptor concentrations.
The biggest weakness of the present study was the failure
to compare the iron status of HIV-infected children with
non-HIV-infected controls. However, iron depletion was
widespread, and IDA was far more prevalent than was
documented in a recent national study of more than 6000
South African children [5]. That study was undertaken in
1994, when the prevalence of paediatric HIV infection
was low [19]. The findings of the present study were com-
parable to results obtained in an Italian study evaluating
iron status in HIV-infected children. In the Italian study
iron deficiency, defined as low serum iron concentration,
was present in 48% of HIV-infected children. The present
study employed stricter criteria to define iron status.
Therefore we can conclude that iron depletion and IDA
are significant problems in HIV-infected children in South
Africa.
Many aetiological factors probably contribute to the de-
velopment of low iron status in HIV-infected children, in-
cluding reduced dietary intake, the quality of dietary iron
and altered iron absorption [20]. The Italian study
showed that intestinal malabsorption is a major factor [5].
Whether iron therapy causes deleterious effects in paediat-
ric HIV infection has not been established. In general,
while the relationship between infection and iron status
remains contentious, iron overload is associated with in-
creased susceptibility to certain infections [21]. Therefore,
liberal iron therapy or prophylaxis in HIV-infected chil-
dren may facilitate the development of opportunistic in-
fections. For the present time, HIV-infected children with
IDA should receive therapeutic iron replacement. Howev-
er, more research is required to establish the benefits and
or deleterious effects of iron therapy and prophylaxis in
antiretroviral naive, HIV-infected children, particularly
those with iron depletion.
Abbreviations
ACD Anaemia of chronic diseases
EDTA Ethylene diamine tetra-acetic acid
CDC Centers for Disease Control
Fe Iron concentration
Hb Haemaglobin concentration
HIV-1 Human immunodeficiency virus – type 1
IDA Iron deficiency anaemia
MCH Mean corpuscular haemaglobin
MCHC Mean corpuscular haemaglobin concentration
MCV Mean corpuscular volume
RBC Red blood cell
RDW Red blood cell distribution width
sTfR Soluble transferrin receptor concentration
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